Daejeon, South Korea

Kwang-Woo Jung

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Bioneer Corporation. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kwang-Woo Jung. Retrieved from https://idiyas.com/inventor/kwang-woo-jung-dd67gr9x

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kwang-Woo Jung: Innovator in Cryptococcal Research

Introduction

Kwang-Woo Jung is an inventor based in Seoul, South Korea. He is currently associated with Amtixbio Co., Ltd. Despite having no granted patents, he is actively involved in innovative research related to Cryptococcus neoformans. His work focuses on understanding the virulence of this pathogen and developing potential therapeutic strategies.

Latest Patent Applications

Kwang-Woo Jung's notable patent application is titled "Novel Gene Regulating Virulence of Cryptococcus neoformans, and Use Thereof." This invention pertains to a novel gene that regulates the virulence of Cryptococcus neoformans. The application outlines methods for screening anti-Cryptococcal or anti-fungal drug candidate materials effectively. It also discusses a pharmaceutical composition that can enhance the anti-Cryptococcal or anti-fungal effect by modulating the expression of transcription factors. The research includes large-scale virulence tests using insect and animal models to identify transcription factors and analyze their correlation with pathogenicity.

Conclusion

Kwang-Woo Jung is making significant contributions to the field of microbiology through his innovative research on Cryptococcus neoformans. His work has the potential to lead to new therapeutic approaches for combating fungal infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…